Skip to main content

Table 2 (abstract P035). See text for description

From: 39th International Symposium on Intensive Care and Emergency Medicine

Drug-related adverse events (Grade ≥ 2)

Grade

480 mg nivolumab (n=5)

960 mg nivolumab (n=8)

Alanine aminotransferase increased

4

1 (20.0)*

0 (0.0)

Aspartate aminotransferase increased

3

1 (20.0)*

0 (0.0)

Pruritus

2

1 (20.0)*

0 (0.0)

Rash

2

1 (20.0)*

0 (0.0)

Organizing pneumonia

2

1 (20.0)*

0 (0.0)

  1. n (%), *All drug-related adverse events were observed in the same patient
Back to article page

Critical Care

ISSN: 1364-8535